North Kurzeme Regional Hospital
- Address
- Inzenieru street 60, LV-3601 Ventspils, Latvia
North Kurzeme Regional Hospital - Ophthalmology & Retinal Disease Research
North Kurzeme Regional Hospital serves as an active clinical research site specializing in ophthalmology, with particular expertise in chorioretinal vascular diseases. The center focuses on evaluating innovative drug delivery systems and therapeutic interventions for vision-threatening retinal conditions, contributing to the advancement of treatment options for patients with complex eye diseases.
- Neovascular age-related macular degeneration (nAMD) research
- Diabetic eye disease studies including diabetic macular edema and diabetic retinopathy
- Retinal vein occlusion and myopic choroidal neovascularization investigations
The hospital's research activities emphasize both safety evaluation and device handling assessments for novel pharmaceutical delivery systems. Their participation in chorioretinal vascular disease trials demonstrates commitment to improving treatment modalities for conditions that significantly impact visual function, including diabetic macular edema, retinal vein occlusion, and various forms of choroidal neovascularization.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 80 other sites in Latvia
Therapeutic Area Benchmark — Latvia
Select a therapeutic area to compare against other sites in Latvia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Latvia
Market Share
Country: Latvia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in North Kurzeme Regional Hospital
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Handling and Ocular Safety of Aflibercept Pre-Filled Syringe in Chorioretinal Vascular Diseases: A Single-Arm, Open-Label, Multicenter Study | Alvotech Swiss AG | Phase III | Not Recruiting | Mar 2024 | Mar 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aflibercept | 1 | Unknown | 2024-03-11 | 2024-03-11 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.